eIF4A is frequently activated in neoplasia, either through mRNA overexpression or suppression of the tumor suppressor protein PDCD4 (programmed cell death 4), which competes with eIF4G for binding to eIF4A [109,132,133,134]. Here, EIF4G1 is linked to neoplasm.